Biosimilars: A New Era of Gastroenterology Management Considerations, Part II: Biosimilars and Patients with Inflammatory Bowel Disease


This webcast features a GI nurse, doctor and pharmacist discussing the use of biosimilars in the GI clinic. This module specifically reviews three case studies with IBD and discusses concerns with prescribing biosimilars. Prepare yourself to answer patient questions about biosimilars with confidence!  

The Society of Gastroenterology Nurses and Associates, Inc., is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This course is worth 1.0 contact hour(s).

SGNA is provider-approved by the California Board of Registered Nursing, Provider Number CEP 11579. Check with your state board of nursing for acceptability of education sessions for re-licensure.

ABCGN: According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), 1.0 hour(s) earned in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Contact Hour(s) Expiration: 1/16/2021. 

NOTE: Registration for this product expires after 30 days.


Biosimilars II Course
Begin self-paced component package.
Begin self-paced component package.
5 Questions
1.00 CH credit  |  Certificate available
1.00 CH credit  |  Certificate available